Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Die Highlights vom Kongress des American College of Cardiology 2024

Im April diskutierten die Herz-Kreislauf-Spezialisten aus der ganzen Welt auf dem  Kongress des American College of Cardiology (ACC) u.a. neue Therapieansätze bei akutem Myokardinfarkt, koronarer Herzerkrankung, kardiogenem Schock oder Aortenklappenstenose. In unserem Kongress-Dossier haben wir für Sie Berichte über die „Late-Breaking Trials“ und andere wichtige Studien zusammengestellt. 
Erweiterte Suche
Anmelden
nach oben
Current Diabetes Reports
Erschienen in: Current Diabetes Reports 5/2012

01.10.2012 | Treatment of Type 1 Diabetes (D Dabelea, Section Editor)

Current Concepts and Controversies in Prevention and Treatment of Diabetic Ketoacidosis in Children

verfasst von: Arleta Rewers

Erschienen in: Current Diabetes Reports | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Diabetic ketoacidosis (DKA) is caused by absolute or relative lack of insulin. Lack of insulin leads to hyperglycemia, ketonemia, and acidosis. Prevalence of DKA at diagnosis of type 1 diabetes (T1D) varies around the world from 18 % to 84 %. Incidence of recurrent DKA is higher among females, insulin pump users, those with a history of psychiatric or eating disorder, and suboptimal socioeconomic circumstances. DKA is the most common cause of death in children with T1D. Children with DKA should be treated in experienced centers. Initial bolus of 10–20 mL/kg 0.9 % saline is followed by 0.45 %-0.9 % saline infusion. Fluid infusion should precede insulin administration (0.1 U/kg/h) by 1–2 hours. The prevention of DKA at diagnosis of diabetes can be achieved by an intensive community intervention and education of health care providers to raise awareness. Prevention of recurrent DKA requires continuous patient education and access to diabetes programs and telephone services.
Literatur
1.
Wolfsdorf J, Glaser N, Sperling MA. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:1150–9.PubMedCrossRef
2.
Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care. 2006;29:2739–48.PubMedCrossRef
3.
Dunger DB, Sperling MA, Acerini CL, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child. 2004;89:188–94.PubMedCrossRef
4.
Rewers A, Klingensmith G, Davis C, et al. Diabetes ketoacidosis at onset of diabetes: the SEARCH for diabetes in Youth Study. Diabetes. 2007;54 Suppl 1:A63–4.
5.
Bui H, To T, Stein R, Fung K, Daneman D. Is diabetic ketoacidosis at disease onset a result of missed diagnosis? J Pediatr. 2009;156:472–7.
6.
Hekkala A, Knip M, Veijola R. Ketoacidosis at diagnosis of type 1 diabetes in children in Northern Finland: temporal changes over 20 years. Diabetes Care. 2007;30:861–6.PubMedCrossRef
7.
Neu A, Hofer SE, Karges B, Oeverink R, Rosenbauer J, Holl RW. Ketoacidosis at diabetes onset is still frequent in children and adolescents: a multicenter analysis of 14,664 patients from 106 institutions. Diabetes Care. 2009;32:1647–8.PubMedCrossRef
8.
Karges B, Neu A, Hofer SE, et al. Frequency and influencing factors of ketoacidosis at diabetes onset in children and adolescents–a long-term study between 1995 and 2009. Klin Padiatr. 2011;223:70–3.PubMedCrossRef
9.
Oyarzabal IM, Garcia CB, Barrio CR, et al. Ketoacidosis at onset of type 1 diabetes mellitus in pediatric age in Spain and review of the literature. Pediatr Endocrinol Rev. 2012;9:669–71.
10.
Levy-Marchal C, Patterson CC, Green A. Geographical variation of presentation at diagnosis of type I diabetes in children: the EURODIAB study. European and Diabetes. Diabetologia. 2001;44 Suppl 3:B75–80.PubMedCrossRef
11.
Bui TP, Werther GA, Cameron FJ. Trends in diabetic ketoacidosis in childhood and adolescence: a 15-year experience. Pediatr Diabetes. 2002;3:82–8.PubMedCrossRef
12.
Jackson W, Hofman PL, Robinson EM, Elliot RB, Pilcher CC, Cutfield WS. The changing presentation of children with newly diagnosed type 1 diabetes mellitus. Pediatr Diabetes. 2001;2:154–9.PubMedCrossRef
13.
Abdul-Rasoul M, Habib H, Al-Khouly M. 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr Diabetes. 2006;7:101–7.PubMedCrossRef
14.
bdul-Rasoul M, Al-Mahdi M, Al-Qattan H, et al. Ketoacidosis at presentation of type 1 diabetes in children in Kuwait: frequency and clinical characteristics. Pediatr Diabetes. 2010;11:351–6.CrossRef
15.
Al Rashed AM. Pattern of presentation in type 1 diabetic patients at the diabetes center of a university hospital. Ann Saudi Med. 2011;31:243–9.PubMedCrossRef
16.
Levy-Marchal C, Papoz L, de Beaufort C, et al. Clinical and laboratory features of type 1 diabetic children at the time of diagnosis. Diabet Med. 1992;9:279–84.PubMedCrossRef
17.
Komulainen J, Kulmala P, Savola K, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care. 1999;22:1950–5.PubMedCrossRef
18.
Mallare JT, Cordice CC, Ryan BA, Carey DE, Kreitzer PM, Frank GR. Identifying risk factors for the development of diabetic ketoacidosis in new onset type 1 diabetes mellitus. Clin Pediatr. 2003;42:591–7.CrossRef
19.
Rewers A, Chase HP, Mackenzie T, et al. Predictors of acute complications in children with type 1 diabetes. JAMA. 2002;287:2511–8.PubMedCrossRef
20.
Pinkey JH, Bingley PJ, Sawtell PA, Dunger DB, Gale EA. Presentation and progress of childhood diabetes mellitus: a prospective population-based study. The Bart's-Oxford Study Group. Diabetologia. 1994;37:70–4.PubMedCrossRef
21.
Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM. Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr. 2001;139:197–203.PubMedCrossRef
22.
Childhood Diabetes Research Groups. How frequently do children die at the onset of Insulin-Dependent Diabetes Mellitus? Analyses of registry data from Japan, Poland, the Netherlands, and Allegheny Co., PA. Diab Nutr Metab. 1990;3:57–62.
23.
Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990–1996. Arch Dis Child. 1999;81:318–23.PubMedCrossRef
24.
Curtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care. 2002;25:1591–6.PubMedCrossRef
25.
Lawrence SE, Cummings EA, Gaboury I, Daneman D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. 2005;146:688–92.PubMedCrossRef
26.
Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and outcome of cerebral oedema developing during diabetic ketoacidosis. Arch Dis Child. 2001;85:16–22.PubMedCrossRef
27.
Glaser N, Barnett P, McCaslin I, et al. Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. N Engl J Med. 2001;344:264–9.PubMedCrossRef
28.
Mahoney CP, Vlcek BW, DelAguila M. Risk factors for developing brain herniation during diabetic ketoacidosis. Pediatr Neurol. 1999;21:721–7.PubMedCrossRef
29.
•• Glaser N. Cerebral injury and cerebral edema in children with diabetic ketoacidosis: could cerebral ischemia and reperfusion injury be involved? Pediatr Diabetes. 2009;10:534–41. This paper provides possible explanation of the mechanism of cerebral edema in the course of DKA.PubMedCrossRef
30.
Blamire AM, Anthony DC, Rajagopalan B, Sibson NR, Perry VH, Styles P. Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci. 2000;20:8153–9.PubMed
31.
Hoffman WH, Burek CL, Waller JL, Fisher LE, Khichi M, Mellick LB. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003;108:175–81.PubMedCrossRef
32.
Nadler OA, Finkelstein MJ, Reid SR. How well does serum bicarbonate concentration predict the venous pH in children being evaluated for diabetic ketoacidosis? Pediatr Emerg Care. 2011;27:907–10.PubMedCrossRef
33.
•• Sottosanti M, Morrison GC, Singh RN, et al. Dehydration in children with diabetic ketoacidosis: a prospective study. Arch Dis Child. 2012;97:96–100. This study underlines difficulty in a clinical or laboratory assessment of the degree of dehydration in children with diabetic ketoacidosis. PubMedCrossRef
34.
Fagan MJ, Avner J, Khine H. Initial fluid resuscitation for patients with diabetic ketoacidosis: how dry are they? Clin Pediatr. 2008;47:851–5.CrossRef
35.
Poirier MP, Greer D, Satin-Smith M. A prospective study of the "two-bag system'' in diabetic ketoacidosis management. Clin Pediatr. 2004;43:809–13.CrossRef
36.
Felner EI, White PC. Improving management of diabetic ketoacidosis in children. Pediatrics. 2001;108:735–40.PubMedCrossRef
37.
Adrogue HJ, Barrero J, Eknoyan G. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit. JAMA. 1989;262:2108–13.PubMedCrossRef
38.
Van Zyl DG, Rheeder P, Delport E. Fluid management in diabetic-acidosis–Ringer's lactate versus normal saline: a randomized controlled trial. QJM. 2012;105:337–43.PubMedCrossRef
39.
Savas-Erdeve S, Berberoglu M, Oygar P, et al. Efficiency of fluid treatments with different sodium concentration in children with type 1 diabetic ketoacidosis. J Clin Res Pediatr Endocrinol. 2011;3:149–53.PubMedCrossRef
40.
Burghen GA, Etteldorf JN, Fisher JN, Kitabchi AQ. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care. 1980;3:15–20.PubMedCrossRef
41.
Kitabchi AE. Low-dose insulin therapy in diabetic ketoacidosis: fact or fiction? Diabetes Metab Rev. 1989;5:337–63.PubMedCrossRef
42.
Edge JA, Jakes RW, Roy Y, et al. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia. 2006;49:2002–9.PubMedCrossRef
43.
Kapellen T, Vogel C, Telleis D, Siekmeyer M, Kiess W. Treatment of diabetic ketoacidosis (DKA) with 2 different regimens regarding fluid substitution and insulin dosage (0.025 vs 0.1 units/kg/h). Exp Clin Endocrinol Diabetes. 2012;120:273–6.PubMedCrossRef
44.
Puttha R, Cooke D, Subbarayan A, et al. Low dose (0.05 units/kg/h) is comparable with standard dose (0.1 units/kg/h) intravenous insulin infusion for the initial treatment of diabetic ketoacidosis in children with type 1 diabetes-an observational study. Pediatr Diabetes. 2010;11:12–7.PubMedCrossRef
45.
Al HS, Shann F. Insulin infused at 0.05 vs 0.1 units/kg/hr in children admitted to intensive care with diabetic ketoacidosis. Pediatr Crit Care Med. 2011;12:137–40.CrossRef
46.
Adrogue HJ, Lederer ED, Suki WN, Eknoyan G. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine. 1986;65:163–72.PubMed
47.
•• Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis - a systematic review. Ann Intensive Care. 2011;1:23. This extensive review of existing evidence supports current recommendation regarding role of bicarbonate in treatment of DKA.PubMedCrossRef
48.
Muir AB, Quisling RG, Yang MC, Rosenbloom AL. Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care. 2004;27:1541–6.PubMedCrossRef
49.
Glasgow AM. Devastating cerebral edema in diabetic ketoacidosis before therapy. Diabetes Care. 1991;14:77–8.PubMed
50.
Curtis JR, Bohn D, Daneman D. Use of hypertonic saline in the treatment of cerebral edema in diabetic ketoacidosis (DKA). Pediatr Diabetes. 2001;2:191–4.PubMedCrossRef
51.
• Seewi O, Vierzig A, Roth B, Schonau E. Symptomatic cerebral oedema during treatment of diabetic ketoacidosis: effect of adjuvant octreotide infusion. Diabetol Metab Syndr. 2010;2:56. This paper provides a new therapeutic options for treatment of cerebral edema.PubMedCrossRef
52.
Bosnak M, Dikici B, Dogru O, Davutoglu M, Haspolat K. Somatostatin therapy in the management of resistant diabetic ketoacidosis. Diabetes Care. 2002;25:629–30.PubMedCrossRef
53.
Tasker RC, Lutman D, Peters MJ. Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005;6:405–11.PubMedCrossRef
54.
Marcin JP, Glaser N, Barnett P, et al. Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema. J Pediatr. 2002;141:793–7.PubMedCrossRef
55.
Hoffman WH, Steinhart CM, el Gammal T, Steele S, Cuadrado AR, Morse PK. Cranial CT in children and adolescents with diabetic ketoacidosis. AJNR Am J Neuroradiol. 1988;9:733–9.PubMed
56.
Glaser NS, Wootton-Gorges SL, Buonocore MH, et al. Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr Diabetes. 2006;7:75–80.PubMedCrossRef
57.
Rewers A, McFann K, Chase HP. Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in children. Diabetes Technol Ther. 2006;8:671–6.PubMedCrossRef
58.
Byrne HA, Tieszen KL, Hollis S, Dornan TL, New JP. Evaluation of an electrochemical sensor for measuring blood ketones. Diabetes Care. 2000;23:500–3.PubMedCrossRef
59.
Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med. 2001;18:640–5.PubMedCrossRef
60.
Guerci B, Benichou M, Floriot M, et al. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care. 2003;26:1137–41.PubMedCrossRef
61.
Hoffman WH, O'Neill P, Khoury C, Bernstein SS. Service and education for the insulin-dependent child. Diabetes Care. 1978;1:285–8.PubMedCrossRef
62.
Drozda DJ, Dawson VA, Long DJ, Freson LS, Sperling MA. Assessment of the effect of a comprehensive diabetes management program on hospital admission rates of children with diabetes mellitus. Diabetes Educ. 1990;16:389–93.PubMedCrossRef
63.
Grey M, Boland EA, Davidson M, Li J, Tamborlane WV. Coping skills training for youth with diabetes mellitus has long-lasting effects on metabolic control and quality of life. J Pediatr. 2000;137:107–13.PubMedCrossRef
64.
Svoren BM, Butler D, Levine BS, Anderson BJ, Laffel LM. Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial. Pediatrics. 2003;112:914–22.PubMedCrossRef
65.
Laffel LM, Wentzell K, Loughlin C, Tovar A, Moltz K, Brink S. Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial. Diabet Med. 2006;23:278–84.PubMedCrossRef
66.
Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8-year study in schools and private practices. Diabetes Care. 1999;22:7–9.PubMedCrossRef
67.
Vanelli M, Chiari G, Lacava S, Iovane B. Campaign for diabetic ketoacidosis prevention still effective 8 years later. Diabetes Care. 2007;30:e12.PubMedCrossRef
68.
Barker JM, Goehrig SH, Barriga K, et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care. 2004;27:1399–404.PubMedCrossRef
69.
Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med. 2002;346:1685–91.
70.
Elding LH, Vehik K, Bell R, et al. Reduced prevalence of diabetic ketoacidosis at diagnosis of type 1 diabetes in young children participating in longitudinal follow-up. Diabetes Care. 2011;34:2347–52.CrossRef
Metadaten
Titel
Current Concepts and Controversies in Prevention and Treatment of Diabetic Ketoacidosis in Children
verfasst von
Arleta Rewers
Publikationsdatum
01.10.2012
Verlag
Current Science Inc.
Erschienen in
Current Diabetes Reports / Ausgabe 5/2012
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-012-0307-2

Weitere Artikel der Ausgabe 5/2012

Current Diabetes Reports 5/2012 Zur Ausgabe

Treatment of Type 1 Diabetes (D Dabelea, Section Editor)

Adipose Tissue, Hormones, and Treatment of Type 1 Diabetes

Treatment of Type 1 Diabetes (D Dabelea, Section Editor)

Stem Cell Educator Therapy and Induction of Immune Balance

Treatment of Type 1 Diabetes (D Dabelea, Section Editor)

Continuous Glucose Monitoring in Children and Adolescents

Pathogenesis of Type 1 Diabetes (AG Ziegler, Section Editor)

Anti-Inflammatory Therapy in Type 1 Diabetes

Transplantation (A Pileggi, Section Editor)

Recovery of Endocrine Function After Islet and Pancreas Transplantation

Pathogenesis of Type 1 Diabetes (AG Ziegler, Section Editor)

Treg Vaccination with a Strong-Agonistic Insulin Mimetope

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise